Article Details
Retrieved on: 2023-10-04 19:15:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company plans to begin a phase 3 trial for its mRNA-1083 investigational combination vaccine later this year.
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here